Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2α

This publication has 13 references indexed in Scilit:

• Ligand binding to thromboxane receptors on human platelets: correlation with biological activity
  British Journal of Pharmacology, 1983
• Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1983
• Prostaglandin F2α antagonizes thromboxane A2-induced human platelet aggregation
  Prostaglandins, 1982
• Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators
  Blood, 1981
• Inhibition of platelet adenylate cyclase by ADP
  Thrombosis Research, 1980
• 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
  Proceedings of the National Academy of Sciences, 1979
• Blockade by N-methylhydroxylamine or activation of guanylate cyclase and elevations of guanosine 3′,5′-monophosphate levels in nervous tissues
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1978
• Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
  Prostaglandins, 1977
• Interrelationships between Ca2+ and adenylate and guanylate cyclases in the control of platelet secretion and aggregation.
  Proceedings of the National Academy of Sciences, 1976
• Effects of the Numbers and Sizes of Platelet Aggregates on the Optical Density of Plasma
  Nature, 1967